Quanterix Corp (QTRX):企業の製品パイプライン分析2018

【英語タイトル】Quanterix Corp (QTRX) - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C2870)・商品コード:DATA904C2870
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:40
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Quanterix Corp (Quanterix) is a medical equipment provider that offers proteins measurement solutions. The company’s products include biomarker detection system, assay kits, single molecule detector and analyzers. It provides clinical sample and outsourced testing, custom assay development, assay feasibility testing and prototype development, assay optimization and assay validation through its innovative accelerator lab. Quanterix’s technologies are used in life sciences research, oncology, neurology, inflammatory disease and infectious disease areas. The company offers certificates for analysis that are conducted using its products. It partners with sports and healthcare sectors to detect symptoms and signs of injuries. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quanterix Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Quanterix Corp Company Overview 5
Quanterix Corp Company Snapshot 5
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Quanterix Corp – Pipeline Analysis Overview 8
Quanterix Corp – Key Facts 8
Quanterix Corp – Major Products and Services 9
Quanterix Corp Pipeline Products by Development Stage 10
Quanterix Corp Pipeline Products Overview 12
AccuPSA Test 12
AccuPSA Test Product Overview 12
Antigen Detection Assay – Tuberculosis 13
Antigen Detection Assay – Tuberculosis Product Overview 13
Blood Test – Concussions/TBI 14
Blood Test – Concussions/TBI Product Overview 14
Diagnostic Blood Test – Huntington’s Disease 15
Diagnostic Blood Test – Huntington’s Disease Product Overview 15
Digital ELISA – Crohn’s Disease 16
Digital ELISA – Crohn’s Disease Product Overview 16
Digital ELISA Assay – C. Difficile 17
Digital ELISA Assay – C. Difficile Product Overview 17
NeuroFilament Light Assay – Alzheimer’s Disease 18
NeuroFilament Light Assay – Alzheimer’s Disease Product Overview 18
POC Device – Neurological Injuries 19
POC Device – Neurological Injuries Product Overview 19
Simoa 3.0 20
Simoa 3.0 Product Overview 20
Simoa 4.0 21
Simoa 4.0 Product Overview 21
Simoa 5.0 22
Simoa 5.0 Product Overview 22
SiMoA HD-1 Analyzer – Botulinum Toxin Assay 23
SiMoA HD-1 Analyzer – Botulinum Toxin Assay Product Overview 23
Simoa HD-1 Analyzer – Lung Cancer 24
Simoa HD-1 Analyzer – Lung Cancer Product Overview 24
Simoa HD-1 Analyzer – Pancreatic Cancer 25
Simoa HD-1 Analyzer – Pancreatic Cancer Product Overview 25
SiMoA HD-1 Analyzer – Prostate Cancer Assay 26
SiMoA HD-1 Analyzer – Prostate Cancer Assay Product Overview 26
Quanterix Corp – Key Competitors 27
Quanterix Corp – Key Employees 28
Quanterix Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Quanterix Corp, Recent Developments 30
May 09, 2018: Quanterix Releases Operating Results for First Quarter 2018 30
Apr 27, 2018: Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone 30
Mar 14, 2018: Quanterix Releases Operating Results for Fourth Quarter and Fiscal Year 2017 31
Mar 08, 2018: New Research Demonstrates Enhanced Sensitivity for Acute HIV Detection Using Quanterix’ Simoa Technology 32
Jan 15, 2018: Quanterix Developing Biomarkers for Concussions 33
Jan 10, 2018: Quanterix: Results of Operations and Financial Condition 34
Nov 10, 2017: Quanterix to Showcase New SR-X Ultra-Sensitive Biomarker Detection System at Neuroscience 2017 34
Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017 35
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 36
Sep 07, 2017: Quanterix To Host Webinar On Predicting The Progression Of Neurodegeneration With A Blood Test 36
Appendix 37
Methodology 37
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Quanterix Corp Pipeline Products by Equipment Type 6
Quanterix Corp Pipeline Products by Indication 7
Quanterix Corp, Key Facts 8
Quanterix Corp, Major Products and Services 9
Quanterix Corp Number of Pipeline Products by Development Stage 10
Quanterix Corp Pipeline Products Summary by Development Stage 11
AccuPSA Test - Product Status 12
AccuPSA Test - Product Description 12
Antigen Detection Assay - Tuberculosis - Product Status 13
Antigen Detection Assay - Tuberculosis - Product Description 13
Blood Test - Concussions/TBI - Product Status 14
Blood Test - Concussions/TBI - Product Description 14
Diagnostic Blood Test - Huntington’s Disease - Product Status 15
Diagnostic Blood Test - Huntington’s Disease - Product Description 15
Digital ELISA - Crohn’s Disease - Product Status 16
Digital ELISA - Crohn’s Disease - Product Description 16
Digital ELISA Assay - C. Difficile - Product Status 17
Digital ELISA Assay - C. Difficile - Product Description 17
NeuroFilament Light Assay - Alzheimer’s Disease - Product Status 18
NeuroFilament Light Assay - Alzheimer’s Disease - Product Description 18
POC Device - Neurological Injuries - Product Status 19
POC Device - Neurological Injuries - Product Description 19
Simoa 3.0 - Product Status 20
Simoa 3.0 - Product Description 20
Simoa 4.0 - Product Status 21
Simoa 4.0 - Product Description 21
Simoa 5.0 - Product Status 22
Simoa 5.0 - Product Description 22
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status 23
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description 23
Simoa HD-1 Analyzer - Lung Cancer - Product Status 24
Simoa HD-1 Analyzer - Lung Cancer - Product Description 24
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Status 25
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Description 25
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status 26
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description 26
Quanterix Corp, Key Employees 28
Quanterix Corp, Subsidiaries 29
Glossary 39

List of Figures
Quanterix Corp Pipeline Products by Equipment Type 6
Quanterix Corp Pipeline Products by Development Stage 10

★調査レポート[Quanterix Corp (QTRX):企業の製品パイプライン分析2018] (コード:DATA904C2870)販売に関する免責事項を必ずご確認ください。
★調査レポート[Quanterix Corp (QTRX):企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆